The Ecotrackers Network Foundation, which since 2000 has been developing smart and community tourism, and called smart tourism thanks to its researchers and volunteers, has found a plant to solve respiratory problems and face the mortality caused by the covid-2 or coroana virus
Many of the volunteers, students and researchers, who were helped by the Ecotrackers Network, did research work on medicinal plants. But one of its members, me, Dr. Maximiliano Moreno, researched medicinal plants and native foods since 1982 when I conducted research on medicinal plants and foods from the Esmeraldas Province and the cloud forest, in support of the research on pre-Columbian foods that Dr. Eduardo Estrella my professor at the Faculty of Medicine, former director of the National Institute of Nutrition, investigated, which were published in his book the Bread of America.
Since 1983 as a professor of social medicine at the School of Medical Technology and Director of the Audiovisual Center of the Faculty of Medicine of the Central University, I developed a study on medicinal plants as part of the classes on the history and geography of diseases, which served as the basis for In 2010 I produced a TV series for public television, Ecuador TV: the series Salud y Vida en la Mitad del Mundo and I studied guaviduca with the Faculty of Biochemistry and Pharmacy of the Central University.
As a doctor in Atacames in 1984 I made the use of guaviduca in patients with typhoid and malaria, a plague of two diseases that simultaneously affected disastrously after the El Niño phenomenon of 1982, the use of guaviduca as an antispasmodic and supplement in rehydration succeeding. oral.
Since 1987 as a medical researcher at CIESPAL I have produced a documentary on cholera in Ecuador in which to the rehydration necessary to save lives, we added guaviduca as an antispasmodic successfully when vomiting was overcome. to alleviate abdominal pain prior to appalling diarrhea.
1989 as associate researcher of the Museum of the History of Medicine and medical researcher of malaria for the University of Hidelberg, in the Province of Esmeraldas, in which we investigated the use of awnings with pyrethrum in awnings, pyrethrum is an insecticidal plant from Ecuador , researched and used by the Nazis, I also investigated the use of guaviduca in the management of oral rehydration in decomposed malaria patients with severe dehydration from fevers and colic.
Since 1986 I collaborated with the Faculty of Chemistry and Pharmacy to research guaviduca, a medicinal plant that used it, and produced it as a dry leaf for the treatment of intestinal disorders, and sold it in covers through my company for the production and marketing of medicinal plants Ecuaplanta.
As a doctor in Atacames in 1984 I made the use of guaviduca in patients with typhoid and malaria, a plague of two diseases that simultaneously affected disastrously after the El Niño phenomenon of 1982, the use of guaviduca as an antispasmodic and supplement in rehydration succeeding. oral.
Since 1987 as a medical researcher at CIESPAL I have produced a documentary on cholera in Ecuador in which to the rehydration necessary to save lives, we added guaviduca as an antispasmodic successfully when vomiting was overcome. to alleviate abdominal pain prior to appalling diarrhea.
1989 as associate researcher of the Museum of the History of Medicine and medical researcher of malaria for the University of Hidelberg, in the Province of Esmeraldas, in which we investigated the use of awnings with pyrethrum in awnings, pyrethrum is an insecticidal plant from Ecuador , researched and used by the Nazis, I also investigated the use of guaviduca in the management of oral rehydration in decomposed malaria patients with severe dehydration from fevers and colic.
Since 1986 I collaborated with the Faculty of Chemistry and Pharmacy to research guaviduca, a medicinal plant that used it, and produced it as a dry leaf for the treatment of intestinal disorders, and sold it in covers through my company for the production and marketing of medicinal plants Ecuaplanta.
Since 1992 as an exporter and marketer of medicinal flowers and plants in Ecuador and Russia, I have been studying guaviduca with the Lomonosov University in Moscow, where my company Ecuaplanta its winery of flowers and medicinal plants and registration in Russia.
But the economic crises in Russia first and then in Ecuador that affected my company prevented me from continuing to finance and complete the studies on guaviduca.
In 1996 I collaborated with GTZ for an investigation on the non-timber use of the Forest in Ecuador and we signed an agreement for the study and patent rights of a medicinal plant, of the piperácea by then an unclassified, at the German Embassy in Ecuador, The plant studies would be done by Professor Nitz of the University of Munich.
In 1996 I went to Frankfurt, to the GTZ headquarters to find out about the results of the investigation and they gave me informally on a non-letterhead, without stamps or formalities, the results. University of Munich and GTZ ratified for me by the active principles of the plant what the popular knowledge said, that the plant was used for treatment of liver diseases, since it was a family of boldo, it was antispasmodic, but the novelty was that it was used for respiratory diseases as an adjunct or complementary therapy, even for tuberculosis.
Despite the fact that tuberculosis became a global epidemic and is a pathology that accompanies HIV, AIDS became a pandemic, as it is until now, since HIV reduces defenses, and kills in the fields of poor countries by malaria, which became known as supermalaria, and through tuberculosis, in poor urban areas through the so-called super tuberculosis, which is mandatory in preventive medical care, to carry out tests against tuberculosis in patients with more than 15 days of cough, since this disease has gone global again despite the BCG vaccine,
However, from all these efforts, to date we have not been able to use this plant in the treatment of patients with respiratory problems because there were changes in Ecuadorian legislation and in the agreements on intellectual property signed between Ecuador and the European Economic Community, it is not recognized the patent or intellectual property of medicinal plants is in the interest of the University of Munich, since as they cannot have intellectual property rights, it is not possible to recover the expenses, nor to compensate the time and work done.
The new Ecuadorian legislation that prohibits patents originating in Ecuador's natural products, which was the result of the theft of intellectual property on three active and use principles that had been obtained by pharmaceutical companies such as PFIZER, which was developing a more powerful anesthetic that the morphine of the tricolor toad, and the theft of intellectual property from indigenous people by an American who had patented the use of drago blood and ayahuasca in the United States.
This also led to disinterest on the part of Germany, and the University of Munich to continue the investigation as we had agreed in the German Embassy in Ecuador and to the use and registration of patents of the products obtained from these investigations.
Since 2000, with the Ecotrackers Foundation, I have worked with foreign volunteers, in the research, use and protection of medicinal plants and ancestral knowledge, some of whose works are published in the Ecotrackers blogs and in the videos of Health and Life in the Middle of the World. Ecotrackers
Since 2008, as a doctor from the Ministry of Health in sensitive areas such as the northern border in times of Plan Colombia, the war against drug trafficking and the FARC, in the province of Carchi, the SARS epidemic, AHINI, where I successfully used the guaviduca to treat patients with this disease in La Concepción and especially in the Parish of San Juan de Lachas with the Awa nationality, very reluctant to medications. Both parishes in the troubled area of the Mira River that flows into Tumaco, were territory of armed conflict on the western border of southern Colombia and northern Ecuador.
Since 2011, times of the dengue, Chicungunya, Sika epidemics and the earthquake swarm from April 16, 2016 to February 2017 in the South of Esmeraldas, as a doctor of the Social Security Peasant dispensaries in Muisne, investigate and I developed the use of medicinal plants, especially tobacco, guaviduca and holy spirit when AH1N or swine flu reappeared, in addition to studying other plants such as sea and beach waters, solar radiation, the moon, altitude and the quality of water and air as therapeutic resources for I also continued with the studies begun in 1982 of native foods, as therapeutic resources to develop health tourism to the Galera San Francisco Marine Reserve.
Since 2017 I have resumed the research and use of medicinal plants, of rural medicine. traditional medicine, environmental medicine and Ecuadorian telemedicine to develop to develop health tourism to healing places such as hot springs, beaches, mountains, or forests such as the cloud forest, the Galera San Francisco Reserve on the Coast, Quilotoa in the Andes and Arajuno and the Morona River in the Amazon because they can steal from us the price of our raw materials, our food or medicinal plants and they can produce them elsewhere, but they cannot steal the Andes, the Amazon, the Coast and the Ocean. Pacific nor our ancestral cultures, but they can rob us of our healing places.
In Tandapi, just an hour and a half from Quito, we are creating a center for research and use of the cloud forest and its plants, food, radiation, humidity and height as a therapeutic resource.
Among the plants we work on in the cloud forest is the guaviduca.
This emergency due to the pandemic added to the economic crisis produced by the government and the quarantine emergency forces me and the Ecotrackers Foundation to offer this therapeutic alternative, which is immediately at hand to the populations of Ecuador, Colombia, Peru, Bolivia, and Venezuela that are hit by political, economic and pandemic crises in a particular way, as our countries do not have billions to return their inhabitants to normal after this collapse caused by self-isolation and social distance.
To the migratory phenomenon and the protests due to factors specific to each country, now the health crisis of the pandemic and the fall in the price of oil hitting Ecuador and Venezuela above all.
Since 2017 I have resumed the research and use of medicinal plants, of rural medicine. traditional medicine, environmental medicine and Ecuadorian telemedicine to develop to develop health tourism to healing places such as hot springs, beaches, mountains, or forests such as the cloud forest, the Galera San Francisco Reserve on the Coast, Quilotoa in the Andes and Arajuno and the Morona River in the Amazon because they can steal from us the price of our raw materials, our food or medicinal plants and they can produce them elsewhere, but they cannot steal the Andes, the Amazon, the Coast and the Ocean. Pacific nor our ancestral cultures, but they can rob us of our healing places.
In Tandapi, just an hour and a half from Quito, we are creating a center for research and use of the cloud forest and its plants, food, radiation, humidity and height as a therapeutic resource.
Among the plants we work on in the cloud forest is the guaviduca.
This emergency due to the pandemic added to the economic crisis produced by the government and the quarantine emergency forces me and the Ecotrackers Foundation to offer this therapeutic alternative, which is immediately at hand to the populations of Ecuador, Colombia, Peru, Bolivia, and Venezuela that are hit by political, economic and pandemic crises in a particular way, as our countries do not have billions to return their inhabitants to normal after this collapse caused by self-isolation and social distance.
To the migratory phenomenon and the protests due to factors specific to each country, now the health crisis of the pandemic and the fall in the price of oil hitting Ecuador and Venezuela above all.
Until today it is not possible to reestablish contact with the University of Munich to reactivate the studies and results due to the closure of the embassy, the difficulties of communication in Spanish with the University, so with the support of the Ecotrackers Network Foundation we dare to propose the use of guaviduca or piper carpunia as a therapeutic resource to curb the mortality of the coronavirus
The coronavirus pandemic that today attacks Ecuador, a country that after a boom in the government of Rafael Correa, has fallen into an economic, moral and now sanitary crisis in the government of Lenín Moreno, making Guayaquil the focus epidemiological most important in South America and tropical areas of the American continent, creates the need to request health authorities and residents of the country to use guviduca or pipercarpunia as a treatment at hand, since deaths and plague threatens us everyone and the country, despite the great health infrastructure and the extraordinary health network that the Correa government developed, the ineffectiveness with which this network was carried out in the times of Lenin Moreno, have made it a problem rather than in a solution, since patients are cared for in hospitals that do not radically separate infected patients from other patients, so infected patients who carry won the hospitals come to harm others.
In China, hospitals were built only for patients who are victims of the coronavirus. In Ecuador, patients are taken to hospitals, where they convert the doctor, nurse, assistant, and cleaning personnel into contaminants that pass the disease on to other patients, who are not plagued, are operated, subjected to radiation, weak due to other diseases, accidents, etc. but because they are simply hospitalized they are already more vulnerable.
If we add to this that doctors do not have or cannot change gloves, gowns, and masks when they pass from one patient with coronavirus to another, the mere fact of inspecting patients or laboratory workers and those who take the temperature, turns them into transmission vehicles in and out of hospitals.
Managing and spreading the plague has so many new complexities, such that the person doing the diagnostic test, even if they only take the temperature, should change gloves, mask and gown from head to toe to avoid passing the virus to another person who comes just to know whether or not he is a healthy carrier.
Guayaquil, which now does not know what to do with the corpses of the deceased, and Ecuador, which was the first to feel like a coronavirus pandemic in South America, has the possibility of using a medicinal plant that exists in its cloud forest, like Colomibia, Peru and Bolivia, called guaviduca or piper carpunia, as the main therapeutic resource, since in addition to the plague, compulsory quarantine has led their economies to such a collapse, especially Ecuador, that after two weeks of quarantine, the common people have With little money to eat, he cannot pay for basic services, so his suspension has been prohibited for non-payment, including bank loans, leases and worse to pay for private doctors, exams or expensive vaccines.
This medicinal plant can be an urgent alternative for immediate use if the state and people begin to use them, since their production already exists, and will not produce any undesirable effects such as medicines or vaccines, since their use has centuries.
This medicinal plant can have the advantage over any medicine because the medicines can produce undesirable effects, as happened with thalidomide used as medicine against leprosy and until now in psoriasis that produced thousands of children without feet, without hands, or kanamycin an aminoglycoside antibiotic against gram negative bacteria, gentamicin family, which despite 10 years of laboratory studies to be approved by the US FDA, to rule out undesirable effects, produced meniere deafness and vertigo.
In vaccines, the story also has notorious failures as the first vaccine against polio that was injectable and was obtained from attenuated cultures of the virus in the monkey's brain or kidneys and became the first means of spreading HIV. AIDS that later became the worst plague that is spread by sexual intercourse and the use of syringes in drug addicts. Today the polio vaccine is oral and is not grown in monkey parts.
Guaviduca or piper carpunia also has the advantage that it does not affect the human immunological system as antibiotics do, although they help us against bacteria and parasites, at the same time they reduce our immune resistance by reducing the effort of our own system. defense. That is why drugs and vaccines have as their main problem the time they need to do studies in mice and then in humans.
Guaviduca's role is to regulate the body's response so that febrile reactions, coughs, respiratory congestion, or respiratory problems are not such that they do not become the cause of death.
Cordonavirus is leading us to redefine disease prevention and management. Thus, it leads us to redefine medical treatment, which is considered important, and to eliminate the cause that causes the disease, or the so-called etymological cause, be it a bacterium, a virus, a parasite, an accident, dehydration, etc. without estimating the capacity of each human being to withstand injury, attack or imbalance, which may be different from one to another person. There are patients who can react favorably, unfavorably, or without noticeable reaction to the problem.
This is precisely what happens with the many healthy carriers of the coronavirus, who are people who react favorably to the disease or do not react noticeably like children, and young people, but in the elderly or with pre-existing debilitating diseases it is the opposite, they produce insuperable symptoms that trigger a cascade of deadly reactions.
The fundamental objective of the use of guaviduca, as therapeutic resources, is to use non-dangerous and deadly medicinal plants such as shanshi, a plant from which atropine is obtained and is poisonous, or the poppy from which hallucinogens are obtained that create addiction, but a Food plant used as a condiment for centuries, which has the property of regulating the body's response to viral and bacterial diseases that affect the respiratory or digestive tract
